Aetna and Fresenius Medical Care launched a joint program last week in the US to slow down the progression of Chronic Kidney Disease (CKD) for their health insurance customers.
The program is aimed at improving clinical outcomes for patients and reducing costs by facilitating gentler, less costly transitions to dialysis or pre-transplant care. Each member's biometric and health status will be communicated daily through a wireless communication device in order to help the care team identify, address, or even prevent potentially serious complications.
CKD, also known as chronic renal disease, is a progressive loss in kidney function over a period of months or years. It may be caused by diabetes or high blood pressure. CKD is identified by a blood test for creatinine. The new patient-centric care program enhances coordination of care among specialists, primary care providers and nurses. They identify members at risk and improve clinical management in earlier stages of kidney disease. This helps slow down the inevitable progression to kidney failure.